New Analyst Forecast: $HCAT Given 'Overweight' Rating

We just received data on a new analyst forecast for $HCAT. KeyBanc gave a rating of 'Overweight' for $HCAT.

$HCAT Analyst Ratings

Wall Street analysts have issued reports on $HCAT in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• KeyBanc issued a "Overweight" rating on 04/16/2025

To track analyst ratings and price targets for $HCAT, check out Quiver Quantitative's $HCAT forecast page.

$HCAT Price Targets

Multiple analysts have issued price targets for $HCAT recently. We have seen 2 analysts offer price targets for $HCAT in the last 6 months, with a median target of $6.0.

Here are some recent targets:

• An analyst from Stephens set a target price of $5.0 on 03/06/2025
• Sean Dodge from RBC Capital set a target price of $7.0 on 01/14/2025

$HCAT Insider Trading Activity

$HCAT insiders have traded $HCAT stock on the open market 17 times in the past 6 months. Of those trades, 0 have been purchases and 17 have been sales.

Here’s a breakdown of recent trading of $HCAT stock by insiders over the last 6 months:

• DANIEL LESUEUR (Chief Operating Officer) has made 0 purchases and 6 sales selling 60,511 shares for an estimated $382,446.
• BENJAMIN LANDRY (General Counsel) has made 0 purchases and 3 sales selling 35,595 shares for an estimated $241,950.
• JASON ALGER (Chief Financial Officer) sold 19,599 shares for an estimated $163,049
• LINDA LLEWELYN (Chief People Officer) has made 0 purchases and 4 sales selling 20,690 shares for an estimated $134,697.
• KEVIN LEE FREEMAN (Chief Commercial Officer) sold 7,500 shares for an estimated $67,073
• DUNCAN GALLAGHER has made 0 purchases and 2 sales selling 9,000 shares for an estimated $62,599.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$HCAT Hedge Fund Activity

We have seen 81 institutional investors add shares of $HCAT stock to their portfolio, and 70 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• NEPSIS INC. added 1,994,555 shares (+2072.1%) to their portfolio in Q1 2025, for an estimated $9,035,334
• FIRST LIGHT ASSET MANAGEMENT, LLC added 944,631 shares (+22.0%) to their portfolio in Q4 2024, for an estimated $6,678,541
• BANK OF NEW YORK MELLON CORP removed 865,743 shares (-37.6%) from their portfolio in Q4 2024, for an estimated $6,120,803
• ALYESKA INVESTMENT GROUP, L.P. added 861,150 shares (+74.4%) to their portfolio in Q4 2024, for an estimated $6,088,330
• KENNEDY CAPITAL MANAGEMENT LLC added 565,445 shares (+42.7%) to their portfolio in Q4 2024, for an estimated $3,997,696
• GRANAHAN INVESTMENT MANAGEMENT, LLC removed 539,119 shares (-52.2%) from their portfolio in Q4 2024, for an estimated $3,811,571
• PENN CAPITAL MANAGEMENT COMPANY, LLC added 495,945 shares (+inf%) to their portfolio in Q4 2024, for an estimated $3,506,331

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.